Phase II study of acivicin in patients with recurrent high grade astrocytoma

Journal of Clinical Neuroscience

Volumn 5, Issue 1, 1998, Pages 46-48

  Olver, I N ^a,b   Green, M ^a   Millward, M J ^a   Bishop, J F ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Acivicin; Astrocytoma; Brain; Neurotoxicity

Indexed keywords

EID: 0006231048     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(98)90201-6     Document Type: Article

References (12)

1. Walker MD, Green SB, Byar DP et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980; 303: 1323-1329.
2. O'Dwyer PJ, Alonso MT, Leyland-Jones B. Acivicin: a new glutamine antagonist in clinical trials. J Clin Oncol 1984; 2: 1064-1071.
3. Taylor S, Belt RG, Joseph U et al. Phase I evaluation of AT-125 single dose every three weeks. Invest New Drugs 1984; 2: 311-314.
4. Sridhar KS, Onhuma T, Chahinian AP, Holland JF. Phase I study of acivicin in patients with advanced cancer. Cancer Treat Rep 1983; 67: 701-703.
5. Adolphson CC, Ajani JA, Stroehlein JR et al. Phase II trial of acivicin in patients with advanced colorectal carcinoma. Am J Clin Oncol 1986; 9: 189-191.
6. Maroun JA, Maksymiuk A, Eisenhauer E et al. Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study. Cancer Treat Rep 1986; 70: 1327-1328.
7. McGuire WP, Blessing JA, Disaia PJ, Buchsbaum HJ. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma: a Gynaecologic Oncology Group Trial. Invest New Drugs 1986; 4: 49-52.
8. Taylor SA, Crowley J, Pollock TW et al. Objective antitumour activity of acivicin in patients with recurrent CNS malignancies: a Southwest Oncology Group Trial. J Clin Oncol 1991; 9: 1476-1479.
9. Baruchel S, Bernstein M, Devine S, Ragab A, Vietti T. Phase I study of acivicin in paediatric solid tumours. A Paediatric Oncology Group Trial. Proc Am Assoc Cancer Res 1994; 35: A1468.
10. Williams MG, Earhart RH, Baley H, McGovern JP. Prevention of central nervous system toxicity of the antitumour antibiotic acivicin by concomitant infusion of an amino acid mixture. Cancer Res 1990; 50: 5475-5480.
11. Fields S, Rodriguez G, Burris H et al. Concomitant administration of acivicin and aminosyn by continuous infusion (CI). Proc Am Soc Clin Oncol 1993; 12: A427.
12. Poplin E, LoRusso P, Foster B et al. Acivicin by continuous low-dose infusion: a phase I trial. Proc Am Assoc Cancer Res 1991; 32: A1205.